local wnt3a treatment restores bone regeneration in large osseous defects after surgical debridement of osteomyelitis

Impaired bone homeostasis caused by osteomyelitis provokes serious variations in the bone remodeling process, thereby involving multiple inflammatory cytokines to activate bone healing. we have previously established a mouse model for post-traumatic osteomyelitis and studied bone regeneration after sufficient debridement. moreover, we could further characterize the postinfectious inflammatory state of bony defects after debridement with elevated osteoclasts and decreased bone formation despite the absence of bacteria. in this study, we investigated the positive effects of wnt-pathway modulation on bone regeneration in our previous established mouse model. this was achieved by local application of wnt3a, a recombinant activator of the canonical wnt-pathway. application of wnt3a could enhance new bone formation, which was verified by histological and μ-ct analysis. moreover, histology and western blots revealed enhanced osteoblastogenesis and downregulated osteoclasts in a rankl-dependent manner. further analysis of wnt-pathway showed downregulation after bone infections were reconstituted by application of wnt3a. interestingly, wnt-inhibitory proteins dickkopf 1 (dkk1), sclerostin, and secreted frizzled protein 1 (sfrp1) were upregulated simultaneously to wnt-pathway activation, indicating a negative feedback for active form of beta-catenin. in this study, we could demonstrate enhanced bone formation in defects caused by post-traumatic osteomyelitis after wnt3a application.